The Coalition against Typhoid (CaT) and the Typhoid Vaccine Acceleration Consortium (TyVAC) have joined forces to take on typhoid. Together, we are working to focus attention on typhoid prevention and control. These efforts include the introduction of typhoid conjugate vaccines (TCVs) and improved water, sanitation, and hygiene interventions to reduce the burden and impact of typhoid.
CaT, based at the Sabin Vaccine Institute, works to prevent typhoid and other invasive salmonelloses through research, education, and advocacy.
TyVAC is a partnership between the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, the Oxford Vaccine Group at the University of Oxford, and PATH. We work closely with local and global partners to accelerate the introduction of new TCVs.
Join us to #TakeOnTyphoid.
Photo: PATH/Doune Porter